Literature DB >> 35714601

Structures of an active type III-A CRISPR effector complex.

Eric M Smith1, Sé Ferrell1, Valerie L Tokars2, Alfonso Mondragón3.   

Abstract

Clustered regularly interspaced short palindromic repeats (CRISPR) and their CRISPR-associated proteins (Cas) provide many prokaryotes with an adaptive immune system against invading genetic material. Type III CRISPR systems are unique in that they can degrade both RNA and DNA. In response to invading nucleic acids, they produce cyclic oligoadenylates that act as secondary messengers, activating cellular nucleases that aid in the immune response. Here, we present seven single-particle cryo-EM structures of the type III-A Staphylococcus epidermidis CRISPR effector complex. The structures reveal the intact S. epidermidis effector complex in an apo, ATP-bound, cognate target RNA-bound, and non-cognate target RNA-bound states and illustrate how the effector complex binds and presents crRNA. The complexes bound to target RNA capture the type III-A effector complex in a post-RNA cleavage state. The ATP-bound structures give details about how ATP binds to Cas10 to facilitate cyclic oligoadenylate production.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CRISPR; complex with ATP; complex with target RNA; crRNA; cryo-EM; structure; type III-A

Mesh:

Substances:

Year:  2022        PMID: 35714601      PMCID: PMC9357104          DOI: 10.1016/j.str.2022.05.013

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.871


  63 in total

Review 1.  CRISPR-Cas immunity in prokaryotes.

Authors:  Luciano A Marraffini
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

2.  Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.

Authors:  Ning Jia; Charlie Y Mo; Chongyuan Wang; Edward T Eng; Luciano A Marraffini; Dinshaw J Patel
Journal:  Mol Cell       Date:  2018-11-29       Impact factor: 17.970

3.  Structure and RNA-binding properties of the type III-A CRISPR-associated protein Csm3.

Authors:  Ajla Hrle; Andreas A H Su; Judith Ebert; Christian Benda; Lennart Randau; Elena Conti
Journal:  RNA Biol       Date:  2013-09-30       Impact factor: 4.652

4.  A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems.

Authors:  Migle Kazlauskiene; Georgij Kostiuk; Česlovas Venclovas; Gintautas Tamulaitis; Virginijus Siksnys
Journal:  Science       Date:  2017-06-29       Impact factor: 47.728

5.  Broad Targeting Specificity during Bacterial Type III CRISPR-Cas Immunity Constrains Viral Escape.

Authors:  Nora C Pyenson; Kaitlyn Gayvert; Andrew Varble; Olivier Elemento; Luciano A Marraffini
Journal:  Cell Host Microbe       Date:  2017-08-17       Impact factor: 21.023

6.  CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies.

Authors:  C Pourcel; G Salvignol; G Vergnaud
Journal:  Microbiology (Reading)       Date:  2005-03       Impact factor: 2.777

Review 7.  Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants.

Authors:  Kira S Makarova; Yuri I Wolf; Jaime Iranzo; Sergey A Shmakov; Omer S Alkhnbashi; Stan J J Brouns; Emmanuelle Charpentier; David Cheng; Daniel H Haft; Philippe Horvath; Sylvain Moineau; Francisco J M Mojica; David Scott; Shiraz A Shah; Virginijus Siksnys; Michael P Terns; Česlovas Venclovas; Malcolm F White; Alexander F Yakunin; Winston Yan; Feng Zhang; Roger A Garrett; Rolf Backofen; John van der Oost; Rodolphe Barrangou; Eugene V Koonin
Journal:  Nat Rev Microbiol       Date:  2019-12-19       Impact factor: 60.633

8.  A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes.

Authors:  Daniel H Haft; Jeremy Selengut; Emmanuel F Mongodin; Karen E Nelson
Journal:  PLoS Comput Biol       Date:  2005-11-11       Impact factor: 4.475

9.  Structural organization of a Type III-A CRISPR effector subcomplex determined by X-ray crystallography and cryo-EM.

Authors:  Bryan W Dorsey; Lei Huang; Alfonso Mondragón
Journal:  Nucleic Acids Res       Date:  2019-04-23       Impact factor: 16.971

10.  Structure and mechanism of a Type III CRISPR defence DNA nuclease activated by cyclic oligoadenylate.

Authors:  Stephen A McMahon; Wenlong Zhu; Shirley Graham; Robert Rambo; Malcolm F White; Tracey M Gloster
Journal:  Nat Commun       Date:  2020-01-24       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.